Home » Case Studies » Value Access and Pricing » Risk Mitigation and Contractin…

Risk Mitigation and Contracting Strategies

CBPartners engaged USA physicians and payers to drive pricing and access implications for PRODUCT X’s follow on indication in mGC.


Understand PRODUCT X value proposition in […] (HER2+ 2L mGC) with key physician, payer, and practice admin customers, and provide guidance on implementing a strategy to maximize uptake and access.  



Conduct secondary research to develop disease landscape overview, qualitative research with n=25 payers, n=12 KOLs, and n=5 oncology practice managers to capture PRODUCT X utilization in its metastatic gastric cancer (mGC) follow-on indication independent of price, characterize perceptions on price, and test other priority scenarios.


  • Comprehensive disease landscape overview.
  • Detailed primary research findings report including findings from N=42 qualitative samples.
  • Pricing analysis amongst target segment oncologists for PRODUCT X’s follow-on mGC indication.

Illustrative Outputs


CBP identified key target product profile (TPP) value drivers across stakeholder types, driving development of risk mitigation and contracting strategies to support a premium pricing strategy.